Dr. Chan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
245 Fifth Avenue
Third Floor
New York, NY 10016Phone+1 212-606-3780Fax+1 212-606-3785- Is this information wrong?
Education & Training
Ohio State University HospitalResidency, Dermatology, 2012 - 2015
University Hospitals2008 - 2011
Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 2007 - 2008
Boston University School of MedicineClass of 2007, MD, PhD
Certifications & Licensure
FL State Medical License 2021 - 2026
SD State Medical License Active through 2025
CO State Medical License 2015 - 2025
TX State Medical License 2022 - 2025
NY State Medical License 2015 - 2024
OH State Medical License 2007 - 2015- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Castle Connolly Top Doctors New York City Metro Region Castle Connolly, 2022-2024
- First Place - Research Presentation Ohio Dermatological Association, 2010
- First Place - Research Presentation Case Comprehensive Cancer Center Retreat, 2010
Clinical Trials
- O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma Start of enrollment: 1999 Apr 01
- O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma Start of enrollment: 2010 Feb 01
Publications & Presentations
PubMed
- Attenuation of Human Growth Hormone-Induced Rash With Graded Dose Challenge.Jake Mann, Dennis Caruana, Evelyn Luo, Eric Gottesman, Nidhi Agrawal, Daniel Lozeau, Justina Hessel, Melissa Neumann, Sameer Khanijo, Zubair Hasan, Khizer Rizvi, Regin...> ;Cureus. 2022 Aug 1
- 3 citationsEvaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.Joselin D. Tacastacas, Derek V. Chan, Sean Carlson, Stanton L. Gerson, Afshin Dowlati, Pingfu Fu, Kurt Q Lu, Sarah G. Groft, Julie Rosenjack, Kord Honda, Thomas S. McC...> ;JAMA Dermatology. 2017 May 1
- 1 citationsHLA-DR1 in familial frontal fibrosing alopecia.Derek V. Chan, Joseph M. Flynn, Rebecca Ziegler, Henry K. Wong> ;Journal of the American Academy of Dermatology. 2015 Jul 1
- Join now to see all
Press Mentions
Greater Roslyn Association for Chinese Enrichment Donates PPE to Hospitals, Group Homes in NeedApril 27th, 2020
Dr. Derek V. Chan, Dermatologist with Advanced Dermatology PC, Shares Tips on Five Common Rash-Causing Skin ConditionsOctober 24th, 2019- Skin Tags: Unwelcome Tag-AlongsDecember 2nd, 2016
- Join now to see all
Grant Support
- Elucidation of the Role of GARP/LRRC32 in the Pathogenesis of Psoriasis - 3P50AR055508-03S309National Institutes of Health2010–2011
- Training in Investigative and Molecular Dermatology - NIH 2T32AR007569-16A1National Institutes of Health2009–2010
- End Organ Failure Controlled by IL-2 and Fas - NIH 5R01AR051203-05National Institutes of Health2001–2005
Committees
- Invited Panelist, National Psoriasis Foundation Research Roundtable 2009 - 2009
Industry Relationships
- Patent Licensor, BioLegendLicensing of anti-GARP antibodies for research purposesDisclosure: Royalties [US Patent #20080279834]2011 - Present
- Patent Licensor, MilliporeLicensing of anti-GARP antibodies for research purposesDisclosure: Royalties [US Patent #20080279834]2010 - Present
- Patent Licensor, Becton DickensonLicensing of anti-GARP antibodies for research purposesDisclosure: Royalties [US Patent #20080279834]2010 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
